Dr Tamara Cooper

Dr Tamara Cooper

Senior Research Fellow

School of Pharmacy and Biomedical Science

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

Year Citation
2024 Wang, S., Qiao, X., Cui, Y., Liu, L., Cooper, T., Hu, Y., . . . Wang, X. (2024). NCAPH, ubiquitinated by TRIM21, promotes cell proliferation by inhibiting autophagy of cervical cancer through AKT/mTOR dependent signaling. Cell Death and Disease, 15(8), 16 pages.
DOI Scopus13 WoS13 Europe PMC12
2022 Eldi, P., Cooper, T. H., Prow, N. A., Liu, L., Heinemann, G. K., Zhang, V. J., . . . Hayball, J. D. (2022). The vaccinia-based Sementis Copenhagen Vector coronavirus disease 2019 vaccine induces broad and durable cellular and humoral immune responses. Immunology and Cell Biology, 100(4), 250-266.
DOI Scopus4 WoS3 Europe PMC2
2020 Nguyen, W., Nakayama, E., Yan, K., Tang, B., Le, T. T., Liu, L., . . . Suhrbier, A. (2020). Arthritogenic alphavirus vaccines: serogrouping versus cross-protection in mouse models. Vaccines, 8(2), 209-1-209-26.
DOI Scopus35 WoS35 Europe PMC38
2020 Prow, N. A., Liu, L., McCarthy, M. K., Walters, K., Kalkeri, R., Geiger, J., . . . Suhrbier, A. (2020). The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates. NPJ Vaccines, 5(1, article no. 44), 44-1-44-10.
DOI Scopus21 WoS16 Europe PMC17
2020 Wang, M., Qiao, X., Cooper, T., Pan, W., Liu, L., Hayball, J., . . . Wang, X. (2020). HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway. Cell Death and Disease, 11(12, article no. 1049), 1-16.
DOI Scopus34 WoS38 Europe PMC37
2019 Eldi, P., Cooper, T., Ward, M., & Hayball, J. D. (2019). How emerging vaccine technologies are pushing disease prevention boundaries. International pharmacy journal, 37(1), 16-19.
2018 Prow, N., Liu, L., Nakayama, E., Cooper, T., Yan, K., Eldi, P., . . . Suhrbier, A. (2018). A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses. Nature Communications, 9(1), 1230-1-1230-12.
DOI Scopus72 WoS68 Europe PMC66
2017 Liu, L., Cooper, T., Eldi, P., Garcia-Valtanen, P., Diener, K., Howley, P., & Hayball, J. (2017). Transient dominant host-range selection using Chinese hamster ovary cells to generate marker-free recombinant viral vectors from Vaccinia virus. BioTechniques, 62(4), 183-187.
DOI Scopus4 WoS4 Europe PMC4
2017 Eldi, P., Cooper, T., Liu, L., Prow, N., Diener, K., Howley, P., . . . Hayball, J. (2017). Production of a chikungunya vaccine using a CHO cell and attenuated viral-based platform technology. Molecular Therapy, 25(10), 2332-2344.
DOI Scopus19 WoS19 Europe PMC19
2014 Liu, L., Cooper, T., Howley, P., & Hayball, J. (2014). From crescent to mature virion: vaccinia virus assembly and maturation. Viruses, 6(10), 3787-3808.
DOI Scopus52 WoS43 Europe PMC43
2013 Siddiqui, M., Filomeni, E., Francois, M., Collins, S., Cooper, T., Glatz, R., . . . Leifert, W. (2013). Exposure of insect cells to ionising radiation in vivo induces persistent phosphorylation of a H2AX homologue (H2AvB). Mutagenesis, 28(5), 531-541.
DOI Scopus11 WoS12 Europe PMC7
2011 Cooper, T., Bailey-Hill, K., Leifert, W., McMurchie, E., Asgari, S., & Glatz, R. (2011). Identification of an in vitro interaction between an insect immune suppressor protein (CrV2) and Gα proteins. Journal of Biological Chemistry, 286(12), 10466-10475.
DOI Scopus13 WoS11 Europe PMC6
2010 Leifert, W. R., Glatz, R. V., Bailey, K., Cooper, T., Bally, M., Stadler, B. M., . . . Shapter, J. G. (2010). Nanoscale biosensors and biochips. Annual Review of Nano Research, 3, 1-82.
DOI Scopus5
2009 Cooper, T., McMurchie, E., & Leifert, W. (2009). [³⁵S]GTPγS binding in G protein-coupled receptor assays. Methods in Molecular Biology, 552, 143-151.
DOI Scopus4 Europe PMC4
2008 Cooper, T., Leifert, W., Glatz, R., & McMurchie, E. (2008). Expression and characterisation of functional lanthanide-binding tags fused to a Galpha-protein and muscarinic (M2) receptor. Journal of Bionanoscience, 2(1), 27-34.
DOI Scopus2
2008 Cooper, T. H. J., Leifert, W., Glatz, R. V., & McMurchie, E. J. (2008). Expression and characterisation of functional lanthanide-binding tags fused to a Ga-protein and muscarinic (M2) receptor. Journal of Bionanoscience, 2(1), 27-34.
DOI
2007 Glatz, R., Leifert, W., Cooper, T., Hill, K., Barton, C., Martin, A., . . . McMurchie, E. (2007). Molecular engineering of G protein-coupled receptors and G proteins for cell-free biosensing. Australian Journal of Chemistry, 60(5), 309-313.
DOI Scopus4 WoS3
2006 Leifert, W., Hill, K., Cooper, T., Aloia, A., Glatz, R., & McMurchie, E. (2006). Measurement of heterotrimeric G-protein and regulators of G-protein signaling interactions by time-resolved fluorescence resonance energy transfer. Analytical Biochemistry, 355(2), 201-212.
DOI Scopus20 WoS23 Europe PMC16

Year Citation
2017 Eldi, P., Cooper, T., Liu, L., Howley, P., Smith, W., & Hayball, J. (2017). A NOVEL IMMUNOTHERAPEUTIC VACCINE TO MODULATE CYTOKINE RESPONSES OF ANTIGEN-SPECIFIC CD4<SUP>+</SUP> T CELLS IN PEANUT ALLERGY. In INTERNAL MEDICINE JOURNAL Vol. 47 (pp. 14). WILEY.
DOI
2016 Hayball, J., Liu, L., Cooper, T., Eldi, P., & Howley, P. (2016). SCV platform: a novel replication-incompetent vaccinia viral vaccine vector system. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 1227). AUSTRALIA, Melbourne: WILEY-BLACKWELL.
2016 Hayball, J., Cooper, T., Liu, L., Eldi, P., Tan, M., Prow, N., . . . Howley, P. (2016). A dual Chikungunya and smallpox vaccine derived from a novel, replication-incompetent poxvirus vaccine system provides mice with complete protection from Chikungunya virus and mousepox infection. In EUROPEAN JOURNAL OF IMMUNOLOGY Vol. 46 (pp. 809). AUSTRALIA, Melbourne: WILEY-BLACKWELL.

  • Sementis SCV Vaccine Development Research Fellow Support, Sementis Pty Ltd, 31/12/2025 - 30/06/2026

  • Sementis SCV Vaccine Development Laboratory Reagents and Consumables, Sementis Pty Ltd, 01/01/2026 - 30/06/2026

  • Development of a prototype immunomodulatory vaccine for cat allergy, Sementis Pty Ltd, 02/09/2016 - 19/12/2019

  • Development of a prototype immunomodulatory vaccine for cat allergy, SIEF STEM+ Business Fellowship Program, 02/09/2016 - 02/09/2019

Date Role Research Topic Program Degree Type Student Load Student Name
2020 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Ms Samantha Jane Watson

Connect With Me

External Profiles

Other Links